Irma Tchokhonelidze

TL;DR: Prevalence of chronic kidney disease was high in general and high-risk populations from countries of low and middle income, and awareness of Chronic kidney disease and other non-communicable diseases was low, and a substantial number of individuals who knew they were ill did not receive treatment.

TL;DR: The AURA-LV study suggests that the addition of low-dose voclosporin to mycophenolate mofetil and corticosteroids for induction therapy of active LN results in a superior renal response compared to myCophenolatemofetIL and cortICosteroids alone, but higher rates of adverse events including death were observed.

TL;DR: Significant variation is found in the global density of nephrologists and nephrology trainees and shortages in all care providers inNephrology; the gap was more prominent in low-income countries, particularly in African and South Asian ISN regions.

TL;DR: These comprehensive data show the capacity of countries (including low income countries) to provide optimal care for patients with end stage kidney disease and demonstrate substantial variability in the burden of such disease and capacity for kidney replacement therapy and conservative kidney management, which have implications for policy.

TL;DR: The purpose was to develop a strategic plan to improve worldwide access to integrated ESKD care, by identifying and prioritizing key activities across 8 themes, and an overarching performance framework were developed for each theme.